Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 04, 2012 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation Receives Scientific Advice from European Medicines Agency for AmiKet™ CIPN Program

Requirements Are Consistent with FDA Guidance TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...
May 09, 2012 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports First Quarter 2012 Operating and Financial Results

CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX:...
May 03, 2012 21:01 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Report First Quarter 2012 Operating and Financial Results on May 9, 2012

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that it will host a conference...
April 30, 2012 17:06 ET | Source: Immune Pharmaceuticals Inc

EpiCept Makes Required Swedish Regulatory Disclosure

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--Regulatory News: Pursuant to the requirements of the Swedish Financial Supervisory Authority, EpiCept Corporation (Nasdaq OMX...
April 10, 2012 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept’s AmiKet™ Receives Fast Track Designation from FDA

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that AmiKet™ (amitriptyline 4%,...
April 04, 2012 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept’s Licensed Compound EP1013 Identified as a New Drug Candidate for Treatment of Late-Stage Viral Hepatitis

TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT) announced today that new preclinical research...
March 29, 2012 00:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept to Raise $1.1 Million in Registered Direct Offering

EpiCept to Raise $1.1 Million in Registered Direct Offering TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--EpiCept Corporation (Nasdaq OMX Stockholm Exchange and OTCQX: EPCT)...
March 14, 2012 17:04 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation to Present at the BIO-Europe Spring 2012 Event

EpiCept Corporation to Present at the BIO-Europe Spring 2012 Event BIO-Europe Spring 2012 TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))-- Regulatory News: EpiCept Corporation...
February 29, 2012 05:58 ET | Source: Immune Pharmaceuticals Inc

EpiCept Reports Fourth Quarter and Full Year 2011 Operating and Financial Results

EpiCept Reports Fourth Quarter and Full Year 2011 Operating and Financial Results CONFERENCE CALL BEGINS AT 9:00 A.M. EASTERN TIME TODAY TARRYTOWN, N.Y.--(BUSINESS...
February 23, 2012 17:02 ET | Source: Immune Pharmaceuticals Inc

EpiCept Corporation to Report Fourth Quarter and Full Year 2011 Operating and Financial Results on February 29, 2012

EpiCept Corporation to Report Fourth Quarter and Full Year 2011 Operating and Financial Results on February 29, 2012 TARRYTOWN, N.Y.--(BUSINESS WIRE (http://www.businesswire.com/))--...